Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Odero

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cancer Letters|October 9, 2019
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicityCarmen Vicente, Elena Arriazu, Elena Martínez-Balsalobre, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2Idoya Lahortiga, Elena Belloni, Iria Vázquez, et al.
Cancer Genetics and Cytogenetics|June 14, 2005
Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinibXabier Agirre, José Román-Gómez, Iria Vázquez, et al.
Blood Cancer Journal|January 9, 2020
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemiaElena Arriazu, Carmen Vicente, Raffaella Pippa, et al.
Genes, Chromosomes & Cancer|March 6, 2003
De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19Juan C Cigudosa, Maria D Odero, M José Calasanz, et al.
Leukemia|September 27, 2003
Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization studyJ L García, J M Hernandez, N C Gutiérrez, et al.
The Journal of Clinical Investigation|November 27, 2007
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in miceDanielle C Shing, Maurizio Trubia, Francesco Marchesi, et al.
Oncotarget|October 6, 2016
Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemiaNameeta P Richard, Raffaella Pippa, Megan M Cleary, et al.
Nature Genetics|April 17, 2007
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemiaIdoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, et al.
Blood|December 1, 2022
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulationIrene Peris, Silvia Romero-Murillo, Elena Martínez-Balsalobre, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cancer Letters|October 9, 2019
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicityCarmen Vicente, Elena Arriazu, Elena Martínez-Balsalobre, et al.
Cancer Genetics and Cytogenetics|February 22, 2005
NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2Idoya Lahortiga, Elena Belloni, Iria Vázquez, et al.
Cancer Genetics and Cytogenetics|June 14, 2005
Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinibXabier Agirre, José Román-Gómez, Iria Vázquez, et al.
Blood Cancer Journal|January 9, 2020
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemiaElena Arriazu, Carmen Vicente, Raffaella Pippa, et al.
Genes, Chromosomes & Cancer|March 6, 2003
De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19Juan C Cigudosa, Maria D Odero, M José Calasanz, et al.
Leukemia|September 27, 2003
Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization studyJ L García, J M Hernandez, N C Gutiérrez, et al.
The Journal of Clinical Investigation|November 27, 2007
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in miceDanielle C Shing, Maurizio Trubia, Francesco Marchesi, et al.
Oncotarget|October 6, 2016
Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemiaNameeta P Richard, Raffaella Pippa, Megan M Cleary, et al.
Nature Genetics|April 17, 2007
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemiaIdoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, et al.
Blood|December 1, 2022
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulationIrene Peris, Silvia Romero-Murillo, Elena Martínez-Balsalobre, et al.
Pageof 8